2-Phenylimidazo[1,2-b]pyridazine derivatives highly active against Haemonchus contortus.

Bioorg Med Chem Lett

CSIRO Materials Science and Engineering, Bayview Avenue, Clayton, VIC 3168, Australia.

Published: July 2011

A series of 2-phenylimidazo[1,2-b]pyridazine derivatives were synthesized and evaluated for their in vitro anthelmintic activity against Haemonchus contortus. The most active compounds had in vitro LD(99) values of 30nM, which is comparable to that of the benchmark commercial nematocide, Ivermectin.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2011.05.096DOI Listing

Publication Analysis

Top Keywords

2-phenylimidazo[12-b]pyridazine derivatives
8
haemonchus contortus
8
derivatives highly
4
highly active
4
active haemonchus
4
contortus series
4
series 2-phenylimidazo[12-b]pyridazine
4
derivatives synthesized
4
synthesized evaluated
4
evaluated vitro
4

Similar Publications

7-methyl-2-phenylimidazo[1,2-b]pyridazin-3-carboxylic acid (DM1) and 6-methoxy-2-phenylimidazo[1,2-b]pyridazin-3-carboxylic acid (DM2) have been shown to act as human (h) Cav voltage-gated calcium channel blockers with promising in vivo anti-absence activity, positioning them as potential antiepileptic drugs. The primary aim of this work was to develop cost-effective and environmentally friendly synthetic procedures for preparing 2-phenylimidazo[1,2-b]pyridazine derivatives. After optimizing the synthesis of this compound class using efficient and green techniques such as microwaves and ultrasound irradiation, we further evaluated the antiepileptic effects of DM1 and DM2 in two animal models: CD-1 ICR mice after pentylenetetrazol administration and DBA/2 mice with seizures induced by audiogenic stimuli.

View Article and Find Full Text PDF

3-Methoxy-2-phenylimidazo[1,2-b]pyridazines highly active against Mycobacterium tuberculosis and Mycobacterium marinum.

Eur J Med Chem

November 2023

Drug Discovery Chemistry Team, CSIRO, Clayton, VIC, 3168, Australia. Electronic address:

A series of 3-methoxy-2-phenylimidazo[1,2-b]pyridazine derivatives which were highly active against autoluminescent Mycobacterium tuberculosis (Mtb) and Mycobacterium marinum (Mm) in an in vitro assay were identified. SAR analysis showed that the most active compounds, which included a phenyl group bearing fluoro substituent(s) at C2, a methoxy function at C3, and a benzyl-heteroatom moiety at C6, exhibited in vitro MIC values generally around 0.63-1.

View Article and Find Full Text PDF

2-Phenylimidazo[1,2-b]pyridazine derivatives highly active against Haemonchus contortus.

Bioorg Med Chem Lett

July 2011

CSIRO Materials Science and Engineering, Bayview Avenue, Clayton, VIC 3168, Australia.

A series of 2-phenylimidazo[1,2-b]pyridazine derivatives were synthesized and evaluated for their in vitro anthelmintic activity against Haemonchus contortus. The most active compounds had in vitro LD(99) values of 30nM, which is comparable to that of the benchmark commercial nematocide, Ivermectin.

View Article and Find Full Text PDF

The 6-methoxy-2-phenylimidazo[1,2-b]pyridazine-3-carboxylic acid, DM2, exerts anti-absence activity and blocks Cav3.1 channel, a T-type voltage-dependent Ca(2+) channel subtype, in vitro. The current study investigated the effect of intra-ventrolateral periaqueductal grey (VLPAG) administration of DM2 on formalin-induced nocifensive responses in rats.

View Article and Find Full Text PDF

T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin.

Neuropharmacology

March 2009

Department of Pharmaceutical and Toxicological Chemistry, Faculty of Pharmacy, Federico II University of Naples, Via Domenico Montesano 49, 80131 Naples, Italy.

It is presently unclear whether the antiseizure effects exerted by NSAIDs are totally dependent on COX inhibition or not. To clarify this point we investigated whether 7-methyl-2-phenylimidazo[1,2-b]pyridazine-3-carboxylic acid (DM1) and 6-methoxy-2-phenylimidazo[1,2-b]pyridazine-3-carboxylic acid (DM2), two imidazo[1,2-b]pyridazines structurally related to indomethacin (IDM) but ineffective in blocking COXs, retain IDM antiabsence activity. When administered by intraperitoneal injection in WAG/Rij rats, a rat strain which spontaneously develops SWDs, both DM1 and DM2 dose-dependently suppressed the occurrence of these seizures.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!